Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SGB + Massed PE for PTSD
NCT05889741Phase 2Recruiting
- Sponsor
- UT Health San Antonio
- Start
- Feb 2024
- Primary completion
- Mar 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of ropivacaine in post-traumatic stress disorder (PTSD), sponsored by UT Health San Antonio. Started Feb 2024; status: recruiting.
02
Drugs
ropivacaine
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT05889741.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05889741.